Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease

Author： Mustazza C.   Borioni A.   Giudice M.R.D.   Gatta F.   Ferretti R.   Meneguz A.   Volpe M.T.   Lorenzini P.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.37, Iss.2, 2002-02, pp. : 91-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Persistency of Two Cholinesterase Inhibitors: Rivastigmine versus Donepezil in Elderly Patients with Alzheimer’s Disease

By Suh Dong-Churl  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 695-707

Adis International

Access to resources Recommend Favorite

Review of rivastigmine and its clinical applications in Alzheimer’s disease and related disorders

By Desai A.   Grossberg G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J.   Morris J.C.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite

Rivastigmine often underdosed in Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Rivastigmine on its best behaviour in Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite